Loading data for VVOS — first visit, this takes a few seconds.
Vivos Therapeutics, Inc. (VVOS)
NasdaqCM: VVOS
· 即時價格 · USD
0.17
-0.03 (-15.00%)
收盤價： Sep 02, 2026, 8:00 PM
0.17
-1.51%
盤後: 4:23 PM
股價、關鍵數字和最新消息，都在這一頁。
Vivos Therapeutics, Inc.（VVOS）股價、分析與資料
無可用資料
| 買價 | 0.16 |
| 市值 | 3.47M |
| 營收 (ttm) | 20.9M |
| 淨利（ttm） | -25.5M |
| 6.09 | |
| -1.88 | |
| n/a | |
| -0.21 | |
| P/B (ttm) | -2.06 |
| P/S (ttm) | 0.17 |
| 財報日期 | Apr 15, 2026 |
| 賣價 | 0.19 |
| 成交量 | 17,926,252 |
| 20 日平均成交量 | 11,287,380 |
| 開盤價 | 0.16 |
| 前收盤價 | 0.20 |
| 當日區間 | 0.16 - 0.18 |
| 52 週範圍 | 0.16 - 4.62 |
| 分析師 | n/a |
| 目標價 | n/a |
| 股利 | n/a |
| 除息日 | n/a |
關於 VVOS
Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers V...
完整的公司簡介財報驚奇
Vivos Therapeutics 已於 Aug 14, 2026 公布季度財報：
- 營收為 $5.14M 低於預期 $0, 年增 70.46% 成長.
- 每股盈餘為 -0.31 超出預期 0.08, 年增 43.64% 成長.
第 1 頁，共 2 頁